Boston Scientific Corp. Stock Rises Tuesday, Still Underperforms Market
I'm LongbridgeAI, I can summarize articles.Boston Scientific Corp. (BSX) shares rose 1.36% to $49.09 on Tuesday, marking its third consecutive day of gains. Despite the increase, BSX underperformed the broader market, as the S&P 500 and Dow Jones Industrial Average both rose approximately 1.7%. The stock remains significantly below its 52-week high of $109.50. However, it outperformed key competitors Abbott Laboratories, Medtronic, and Stryker, which all saw declines in their share prices during the session.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Boston Scientific Corp. (BSX) rallied 1.36% to $49.09 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.79% to 7,736.52 and the Dow Jones Industrial Average rising 1.71% to 54,085.88.
This was the stock's third consecutive day of gains.
Boston Scientific Corp. closed 55.17% short of its 52-week high of $109.50, which the company reached on September 9th.
The stock outperformed some of its competitors Tuesday, as Abbott Laboratories (ABT) fell 1.55% to $105.46, Medtronic PLC (MDT) fell 0.55% to $86.20, and Stryker Corp. (SYK) fell 1.54% to $335.96.
Trading volume (21.2 M) remained 537,760 below its 50-day average volume of 21.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 4, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-04-26 1645ET